幽门螺旋杆菌三种药物治疗方案的成本－效果分析

目的 评价不同药物组合方案治疗幽门螺旋杆菌感染所产生的经济效果.方法 运用药物经济学成本-效果分析法对抗幽门螺旋杆菌3种治疗方案进行分析评价.结果 A、B、C三种方案的成本-效果比分别是2.03、2.51和2.53.无论是从成本-效果比分析,还是从增量成本-效果比分析,均得出A方案为抗幽门螺旋杆菌感染的最佳方案.结论 药物经济学的成本-效果分析可为临床医生和患者治疗幽门螺旋杆菌感染提供合理和经济的治疗方案.

Cost-effectiveness analysis on three different therapies for helicobacter pylori infection

Objective To evaluate the cost-effectiveness analysis (CE) of three therapies for helicobacter pylori (Hp) infection. Methods The CE of three therapies for Hp infection was analyzed by the methods of pharmacoeconomics. Results The CE ratios of three therapies in group A, group B and group C were 1.41, 1.43 and 2.24 respectively. From CE analysis and increasing CE analysis, the therapeutic scheme in group A is the best one. Conclusion The rational and economic therapeutic scheme for Hp infection can he acquired by cliniciansand patients using CE analysis of pharmacoeconomics.